Sign Out
Schizophrenia: Acute and maintenance treatment of schizophrenia and related psychoses in adults and adolescents (13 to 17 years old).
Bipolar I Disorder (Manic or Mixed Episodes): As monotherapy for the acute and maintenance treatment of manic or mixed episodes associated with Bipolar I Disorder in adults and adolescents (13 to 17 years old).
Adjunct to valproate or lithium in the treatment of manic or mixed episodes associated with Bipolar I Disorder in adults.
For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.
In combination with fluoxetine: Acute treatment of depressive episodes associated with Bipolar I Disorder in adults and children (10 to 17 years old): Olanzapine monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder.
Acute treatment of treatment-resistant depression in adults (major depressive disorder in patients who do not respond to two separate trials of different antidepressants of adequate dose and duration in the current episode): Olanzapine monotherapy is not indicated for the treatment of treatment-resistant depression.
Continue with Google